CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 227 enrolled
Drug / intervention
3% sodium chloride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01488448
NCT01488448N/ACompleted
CompareCT.gov

A Double-Blind, Controlled, Randomized Clinical Trial of Nebulized Hypertonic Saline for Hospitalized Infants With Viral Bronchiolitis

Montefiore Medical Center·interventional·Posted Dec 8, 2011·Updated Feb 2, 2017

In Brief

A clinical study evaluating 3% sodium chloride and 0.9% sodium chloride for Bronchiolitis. Completed, enrolled 227 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if nebulized hypertonic saline (or extra salty water mist) helps infants less than 12 months old hospitalized with bronchiolitis (or bad chest colds) get better enough to be discharged from the hospital sooner than those infants given nebulized normal saline (or regular salty water mist).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiolitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 8, 2011
Enrollment StartNov 1, 2011
Primary CompletionJul 1, 2014
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 14.6 years ago

Interventions

3% sodium chloridedrug

4 milliliters delivered via nebulizer with 5 Liters O2 flow every 4 hours until discharge

0.9% sodium chloridedrug

4 milliliters delivered via nebulizer with 5 Liters O2 flow every 4 hours until discharge